It can be surprising to learn that lung cancer can develop in people who have never smoked. In fact, up to 20% of lung ...

Severe COVID-19 and influenza infections prime the lungs for cancer and can accelerate the disease’s development, but vaccination heads off those harmful effects, new research indicates.

With lung cancer the leading cause of cancer death both in the UK and globally, the UK's National Health Service (NHS) has launched a trial of AI lung scan analysis and robot-guided biopsies in an ...

February 2026 coverage highlighted combination EGFR therapy guidance, chemo-free treatment options, biomarker testing and ...

Researchers at the University of Gothenburg have identified a protein linked to an increased risk of metastasis and recurrence in lung cancer. The findings are presented in a study that paves the way ...

Professor of epidemiology Mary Charlton speaks to House committees about the key drivers of cancer in Iowa, which has the ...

In recent decades, lung cancer treatment has been transformed—new surgeries, new radiation techniques, and dramatically ...

Researchers compared ACS to USPSTF lung cancer screening criteria, assessing how ACS criteria affected overall eligibility as eligibility in racial/ethnic/gender subgroups.

Lung and breast cancer screening are critical components of global cancer prevention, yet substantial disparities persist in access, uptake, and outcomes ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. In the United States and elsewhere, there’s been a major shift in ...

Experts weigh perioperative immunotherapy delays, rapid molecular testing, ctDNA MRD and emerging ADCs shaping early-stage lung cancer care. In this summary of a panel discussion at the 2026 TTLC ...

Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small cell lung cancer will benefit from immunotherapy.